Poll: What pipeline presbyopia treatment are you most looking forward to?

Poll

This poll is for optometrists and eyecare professionals, only. It will close on Friday, November 5, 2021.

What pipeline presbyopia treatment are you most looking forward to?

A. Orasis CSF-1
B. Allergan AGN-190584 drop
C. Eyenovia MicroLine drop
D. Presbyopia Therapies PRX-100
E. Ocuphire Pharma Nyxol
F. Visus Therapeutics Brimochol

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Subscribe Now!
Recent Videos
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Billy R. Hammond details the study, which explored how HEV-light filtering, specifically in the 380-440 nanometer range, impacts visual comfort for patients with presbyopia.
Kurt Moody, OD, FAAO, describes how to fit multifocal contact lenses in a way that patients love
Jacob R. Lang, OD, FAAO
The ins and outs of fitting multifocal contact lenses with Dr Jessica Crooker
Related Content
Older woman with glasses holding phone at distance Image credit: AdobeStock/KMPZZZ

Tenpoint Therapeutics submits NDA application to US FDA for brimochol PF for the treatment of presbyopia

Jordana Joy, Associate Editor
April 8th 2025
Article
Podcast: Visus presbyopia drop gets FDA IND OK

Podcast: Visus presbyopia drop gets FDA IND OK

Rhett Schiffman, MD, MHSA;Gretchyn M. Bailey, NCLC, FAAO, Editor in Chief, Content Channel Director;Brooke Henson, Editor
April 9th 2021
Podcast
Man administering eye drops Image credit: AdobeStock/9nong

Orasis Pharmaceuticals’ prescription pilocarpine hydrochloride ophthalmic solution 0.4% (Qlosi) for presbyopia available in the US

Sheryl Stevenson, Eye Care Group Editorial Director;Jordana Joy, Associate Editor
April 7th 2025
Article
Podcast: Find out more about Allergan’s presbyopia drop NDA filing

Podcast: Find out more about Allergan’s presbyopia drop NDA filing

Gretchyn M. Bailey, NCLC, FAAO, Editor in Chief, Content Channel Director;Michael Robinson, MD;Brooke Henson, Editor
March 4th 2021
Podcast
Graphic of eye drop Image credit: AdobeStock/Wimon

Advancing presbyopia treatment through optimized design

Jacob R. Lang, OD, FAAO;Jaclyn Garlich, OD, FAAO
April 3rd 2025
Article
Cecelia Koetting, OD, FAAO, DipABO, and Madeline Yung, MD, discussed emerging treatment and patient care options for those with presbyopia during CRU 2025.

CRU 2025: Presbyopia management from topicals to IOLs

Cecelia Koetting, OD, FAAO, DipABO;Jordana Joy, Associate Editor
April 1st 2025
Article
© 2025 MJH Life Sciences

All rights reserved.